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Background: Analysis of the Escherichia coli collection of reference strains (ECOR) for the presence of the gene
locus clyA, which encodes the pore-forming protein ClyA (cytolysin A), revealed that a non-functional clyA locus is
common among certain extraintestinal pathogenic E. coli (ExPEC). In fact, all 15 ECOR group B2 strains and several
additionally examined extraintestinal pathogenic (uropathogenic (UPEC) and neonatal meningitis (NBM)) E. coli
strains contained various ΔclyA alleles.
Results: There are at least four different variants of ΔclyA, suggesting that such deletions in clyA have arisen at
more than one occasion. On the basis of this occurrence of the truncated clyA genes, we considered that there may be
a patho-adaptive selection for deletions in clyA in extraintestinal pathogenic E. coli. In E. coli K-12 the clyA gene has
been viewed as “cryptic” since it is tightly silenced by the nucleoid structuring protein H-NS. We constructed a restored
clyA+ locus in derivatives of the UPEC strain 536 for further investigation of this hypothesis and, in particular, how the
gene would be expressed. Our results show that the level of clyA+ expression is highly increased in the UPEC derivatives
in comparison with the non-pathogenic E. coli K-12. Transcription of the clyA+ gene was induced to even higher levels
when the SfaX regulatory protein was overproduced. The derivative with a restored clyA+ locus displayed a somewhat
slower growth than the parental UPEC strain 536 when a sub-inhibitory concentration of the antimicrobial peptide
Polymyxin B was added to the growth medium.
Conclusions: Taken together, our findings show that the clyA+ locus is expressed at an elevated level in the UPEC
strain and we conclude that this is at least in part due to the effect of the SfaX/PapX transcriptional regulators.
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regulatory proteinBackground
A majority of Escherichia coli strains are benign resi-
dents of the intestinal tract of mammals, however a mi-
nority of E. coli isolates are pathogenic and cause a
variety of diseases ranging from diarrhea to urinary tract
infections and to meningitis. Genes encoding virulence
factors such as adhesins, invasins, and toxins that allow* Correspondence: bernt.eric.uhlin@molbiol.umu.se
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unless otherwise stated.pathogenic E. coli to colonize, invade, and damage host
cells, are often coordinately regulated and tend to be
clustered in the genome.
The ability to lyse erythrocytes (hemolysis) by expres-
sion of hemolysins is a common feature among E. coli
strains causing extraintestinal infections. One of the
most characterized hemolysins is HlyA or α-hemolysin
which is produced by uropathogenic E. coli (UPEC), al-
though several other types of hemolysins have been de-
scribed for E. coli from different patho-groups [1]. The
clyA gene, located at 26.5 min on the E. coli chromosome,td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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and SheA) which causes lysis of mammalian cells by pore
formation in a calcium-independent fashion. ClyA is the
only cytolytic factor found in non-pathogenic strains of
E. coli including the K-12 strains commonly used in la-
boratory studies [2-7]. The clyA+ transcription is known
to be subjected to transcriptional silencing by the H-NS
nucleoid protein in E. coli K-12 [8] and it can be activated
by the transcriptional regulator SlyA [2,4,5,8]. Considering
the strict regulation of clyA in non-pathogenic E. coli
laboratory strains it is of interest to understand how this
gene locus functions in other E. coli isolates. Sequences
homologous to the clyA gene have been identified in a
number of pathogenic isolates of E. coli [2,6,9,10]. In
addition, upon screening of several different Salmonella
enterica serovars, functional homologues to the clyA gene
were identified in the typhoid Salmonella serovars Typhi
and Paratyphi A [9]. The presence of the clyA gene in
wild-type isolates of Salmonella suggests a conserved
function of the gene product although its role in patho-
genesis is unclear. Nevertheless, ClyA appears to be asso-
ciated with virulence in S. enterica. The role of ClyA in
Salmonella virulence was analyzed using the S. enterica
serovars Brandenburg, Indiana, Panama, and Schwarzen-
grund; 21 different serotypes of the strains were examined
and the presence of ClyA was suggested to be associated
with virulence in these S. enterica serovars [11].
In bacteria, the process of adapting to a host may in-
volve not only acquisition of virulence determinants but
also loss of gene functions. Pathogenicity-adaptive, or
patho-adaptive, mutations may represent a genetic means
for enhancing bacterial virulence without horizontal trans-
fer of specific virulence factors, i. e. genes that are detri-
mental to a pathogenic lifestyle are deleted [12]. Such
patho-adaptive mutations, which occur following the ac-
quisition of new genes, may represent fine-tuning of the
genome repertoire of a newly created pathogen to adapt
to its new pathogenic lifestyle [13]. Earlier studies have
provided genetic and/or phenotypic evidence for naturally
occurring mutations that are either required for, or dra-
matically increase the ability of bacteria to enter, spread
within, or sustain themselves in a virulence niche [14,15].
For instance the spontaneous deletion of cadA, encoding
lysine decarboxylase, substantially increases the virulence
of entero-invasive E. coli (EIEC) and Shigella spp. [13].
E. coli is considered to be clonal, and phylogenetic ana-
lyses of this species have shown that the strains fall into
four main groups: A, B1, B2 and D [16]. Recent attempts
to establish a link between phylogeny and virulence sug-
gest that the A and B1 phylogenetic groups should be con-
sidered to represent the normal flora of different
vertebrates, and most human commensal strains originate
from these groups [17-19]. The standard Escherichia coli
collection of reference strains (ECOR), a set of E. colistrains isolated from diverse hosts and geographic loca-
tions, was designed to represent genotypic variation in E.
coli [20]. The collection contains 72 wild-type E. coli iso-
lates from human and 16 other mammalian species, ob-
tained from a larger collection of approximately 2600
isolates [21]. Our previous results clearly showed that the
clyA locus was truncated due to deletion mutations in sev-
eral of the E. coli isolates [22]. One or more deletions in
the clyA locus were found in 15 of 15 tested ECOR B2
strains [22]. Furthermore, deletion mutations in the clyA
locus were identified in two of the 25 (8%) ECOR A
strains, one of the 12 (8%) ECOR D strains and one of the
four (25%) ECOR E strains. In contrast, an intact clyA
locus was found in 100% of the 16 ECOR B1 isolates ex-
amined. The B2 phylogenetic group represents E. coli
strains involved in extra-intestinal infections [19]. The
uropathogenic E. coli isolates 536, J96, and five additional
(strains AD110, DS-17, IA-2, IH11128 and IHE3034; see
Table 1) previously described extra-intestinal pathogenic
(uropathogenic E. coli and newborn meningitis E. coli
(NMEC)) carried a truncated clyA gene. At least four dif-
ferent variants of ΔclyA exist among such strains suggest-
ing that the deletions in clyA arose on more than one
occasion [22]. Similar findings have been reported from
additional surveys of E. coli isolates from different sources
[23-25]. Furthermore, the recent study by Murase and co-
workers showed that gene inactivation at the clyA locus
also has occurred in strains of the ECOR B1 phylogroup
[23-25].
In this report we present findings with derivatives of E.
coli K-12 and the UPEC isolate E. coli 536 in which we
constructed a restored clyA+ locus as well as a clyA-lux
chimeric operon to quantitatively measure expression at
the transcriptional level under different growth conditions.
Results
Deletion mutations at the clyA locus of Escherichia coli
Analysis of the DNA sequences revealed four different
variants (denoted I to IV) of the ΔclyA alleles and differ-
ences in their distribution in the E. coli isolates [22-25].
The strains used in this study are summarized in Table 2
and sequence details are shown in Figure 1. Deletion
variant I include two deletions: one major 493-bp dele-
tion spanning from 164 bp upstream to 329 bp down-
stream of the clyA translational start codon, and one
minor 204-bp deletion spanning from 382 to 585 bp
downstream of the clyA translational start codon. Variant
I was found in 13 of the 15 ECOR B2 strains, in ECOR23
and ECOR24 of group A, and in the UPEC/NBM isolates
AD110, DS17, IA2, IH11128, IHE3034 and J96. Deletion
variant II is similar to variant I, but with an intact 1327-bp
IS-2 element positioned adjacent to the upstream 493-bp
deletion in the opposite orientation of the clyA coding se-
quence. Variant II was found in ECOR61 and ECOR62 of
Table 1 Bacterial strains used in this work
Strain Genotype/relevant characteristics, serotype Reference/source
ECOR collection E. coli reference collection [20]
536 Clinical UTI isolate, O6:K15:H31 [26]
J96 Clinical UTI isolate, O4:K6 [27]
JON47 J96 clyA+ (Kmr) This work
JON53 536 clyA+ (Kmr) This work
COE2 JON53 clyA-luxAB This work
COE3 COE3/pAES1 (sfaX+ clone) This work
COE4 COE2/pBR322 This work
COE6 COE2/pHMG94 (papI+ clone) This work
AD110 Clinical UTI isolate, O6:K2:H1:F7 [28]
DS-17 Clinical UTI isolate, O6:K5 [29]
IA-2 Clinical UTI isolate, O6:H¯ [30]
IH11128 Clinical UTI isolate, O75:K5:H¯ [31]
IHE3034 Clinical NBM isolate, O18:K1 [32]
AES1 sfaX::kan (Kmr) mutant of IHE3034 [33]
AES153 Δ sfaY mutant of IHE3034 This laboratory
DH5α endA1 hsdR17 (rk¯mk
+) supE44 thi-1 recA1 gyrA relA1 Δ(lacZYA-argF) [34]
MG1655 E. coli K-12 wildtype [35]
MC1061 araD139 Δ(ara leu)7697 ΔlacX74galU galK hsr hsm+ strA [36]
M182 Δ(lacIPOZY) X74 galK galU strA [36]
MC4100 araD139Δ(lac)U169 strA thi [37]
BSN26 MC4100 trp::tet (Tcr) [38]
JON33 BSN26 clyA::luxAB [8]
MWK11 MC4100 clyA++ [8]
MWK7 M182 ΔclyA This laboratory
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deletion in the promoter region but in addition had a de-
letion in the clyA coding region. Variant III was identified
in the UTI isolate 536. Deletion variant IV is a 12-bp-long
in-frame deletion from 547 to 558 bp downstream of the
clyA translational start. Variant IV was found in the
ECOR43 and ECOR44 group E and D, respectively.
The presence of a nearly perfect 10-bp repeat
(AGCATTCGCC) immediately upstream of the major
493-bp deletion, and overlapping with the 3′ end of the
deleted segment (AGCATCCGCC) (Figure 1A), sug-
gested that the variant I deletion was the result of a re-
combination event. We found no such DNA repeats that
would explain the internal 204-bp or 217-bp deletions in
the clyA coding sequence (Figure 1B). As shown in the
case of variant IV (Figure 1B) a short 5-bp repeat
(GCCGG) was identified at the junctions of the 12-bp
internal deletion observed in ECOR43 and ECOR44, in-
dicating that this deletion is likely to be the result of a
recombination event. The site of insertion of the IS2
element and the generated 5-bp direct repeats (TTCGC)in ECOR61 and ECOR62 suggested that the IS2 element
was inserted after the deletion was generated (Figure 2A).
Construction of a restored clyA+ locus in the UPEC strain
E. coli 536
To study whether or not the absence of the clyA gene in
extra-intestinal E. coli isolates reflects that this gene may
be disadvantageous for the bacterial cells, clyA+ deriva-
tives of the UPEC strains 536 and J96 were constructed.
We used a suicide plasmid derivative (pJON176) and allelic
exchange to introduce the clyA wild type allele, together
with a kanamycin resistance cassette as a selectable marker
at 350 bp downstream of the clyA stop codon, resulting in
the strains JON47 (J96 clyA+) and JON53 (536 clyA+), re-
spectively. A schematic illustration of the construct JON53
with restored clyA+ locus is shown in Figure 2A. The
strains harboring the clyA+ allele at the correct position on
the chromosome was confirmed by PCR analysis and DNA
sequencing (data not shown). The restored clyA wild type
allele in the UPEC strains was constructed with DNA se-
quences from E. coli K-12 and it was evident that these
Table 2 Distribution of truncated and intact clyA loci in the strains of the ECOR collection and additional
extraintestinal E. coli isolates
Bacterial strain Group1) Serotype clyA locus present2) Deletion variant3)
ECOR1-22, 25 A +
ECOR23-24 A Δ I
ECOR26-30, 32–34, 45, 58, 67-72 B1 +
ECOR51-57, 59–60, 63-66 B2 Δ I
ECOR61-62 B2 Δ II
ECOR35-36, 38–41, 46-50 D +
ECOR44 D Δ IV
ECOR31, 37, 42 E +
ECOR43 E Δ IV
J96 UTI O4:K6 Δ I
536 UTI O6:K15:H31 Δ III
IH11128 UTI O75:K5:H¯ Δ I
AD110 UTI O6:K2:H1:F7 Δ I
DS-17 UTI O6:K5 Δ I
IA-2 UTI O6:H¯ Δ I
IHE3034 NBM O18:K1:H7 Δ I
1)The ECOR subgroups are as defined previously [16].
UTI, urinary tract infection. NBM, newborn meningitis.
2) + denotes that an intact clyA locus is present; Δ denotes that some deletion(s) had ocurred.
3)I-IV denotes the different deletion variants within the clyA locus as described in the text and in Figure 1.
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We performed a multiple sequence alignment of the clyA
promoter region and coding sequences using a large set of
publicly available E. coli genome sequences (NCBI Refer-
ence Sequence: NC_000913.3). It included sequences from
different E. coli pathotypes and from commensally occurring
isolates (see Additional file 1). Inspection of the upstream
region revealed that sequences corresponding to the tran-
scriptional and translational start sequences with the regu-
latory sequence elements (−35, −10, and Shine-Dalgarno
sequences) and binding sites for regulatory proteins (CRP/
FNR, SlyA), as defined from studies of E. coli K-12 deriva-
tives, are conserved among the many different ExPEC and
non-ExPEC E. coli isolates with intact clyA loci.
To assess the level of expression and activity of ClyA
in JON47 and JON53, the hemolytic activity of the
strains was scored on the blood agar plates. We ob-
served a calcium-dependent hemolytic phenotype in
strains JON47 and JON53 when they were grown on
blood agar plates. When the Ca2+ chelator Na-oxalate
was added (final concentration 2 mM), all strains
showed a non-hemolytic phenotype (Figure 2B, panel i).
In our earlier experiments, we showed that lysis of the
host bacterial strains promote the release of ClyA using
lytic bacteriophages or mitomycin C [9]. To deliberately
provoke lysis of the bacterial cells, we placed 2 μl of mi-
tomycin C (from a 1 mg ml−1 stock solution) onto hori-
zontally streaked rows of the strains 536 and J96, andthe clyA+ derivatives JON47 and JON53 on the blood
agar plates (see Methods). Zones of hemolysis appeared
for both JON53 (536 clyA+) and JON47 (J96 clyA+), but
not for the parental strains 536 and J96 (Figure 2B, panel
ii). The results clearly indicated that the restored clyA
locus in these derivatives (JON53 and JON47) of strains
536 and J96 was expressed and our further tests verified
that they could produce the ClyA protein at a detectable
level (Figure 2C, lane 2 for strain JON53 and data not
shown for strain JON47). The presence of ClyA protein
in the clyA+ derivatives was confirmed by Western im-
munoblotting analysis using polyclonal anti-ClyA anti-
serum (Figure 2C). Subcellular localization experiments
showed that ClyA protein was present in the periplasmic
fraction of UPEC derivatives to the same extent as has
been found in the case of E. coli K-12 (Figure 2C, lane 7
for strain JON53 and data not shown for strain JON47).
We showed in earlier studies that in clyA+ E. coli K-12
derivatives, a small subpopulation of bacterial cells
(ca 1-2%) apparently expressed a high enough level of
surface-exposed ClyA to be visible by immunofluores-
cence microscopy [39]. In order to compare the surface
expression and export of ClyA protein in individual bac-
terial cells of the clyA+ UPEC derivative JON53 with the
standard E. coli K-12 strain MG1655, we performed im-
munofluorescence microscopy with anti-ClyA antibodies
and with the UPEC strain 536 used as negative control.
As shown in Figure 3, ClyA was detected on the surface
Figure 1 Sequence representation of the different clyA deletion variants (indicated by roman numerals I-IV) found among different E.
coli isolates with mutant clyA loci: ECOR51 (ΔclyA I), ECOR61 (ΔclyA II), 536 (ΔclyA III) and ECOR43 (ΔclyA IV). Position coordinates are
relative to the clyA start codon in E. coli K-12. Sequence repeats are indicated by red underlined bold face and are highlighted with arrows. The
extent of the IS2 element is indicated by a black bar. (A) Deletions in the clyA upstream region and N-terminal coding sequences. (B) Deletions in
the clyA C-terminal coding sequences.
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munofluorescence detected in case of the E. coli K-12
strain MG1655. Taken together, the studies of ClyA ex-
pression indicated that protein might be present at a
somewhat higher level and/or exposed more abundantly
on the surface of the JON53 bacterial cells in compari-
son with that of the E coli K-12 cells.
Growth phase dependent expression of clyA in JON53
In order to quantitatively monitor the transcriptional ex-
pression level of clyA, a clyA::luxAB operon construct
was integrated in tandem to the clyA+ locus in the
chromosome of JON53 as described in the Methods and
schematically depicted in Figure 2A. The resulting strain
was designated COE2 (JON53 clyA::luxAB). In our earl-
ier studies, we observed the growth phase dependent ex-
pression of the clyA gene in the E. coli K-12 derivative
carrying the clyA::luxAB construct (strain JON33) [8].
The transcription level of the clyA::luxAB operon in
strain COE2 was therefore compared to the level in
strain JON33 throughout the growth cycle. As shown in
Figure 4A, the luciferase activity of the UPEC derivative
COE2 increased continuously during the exponentialgrowth phase and peaked at the late logarithmic phase
of growth where it showed a more than five-fold in-
crease compared to the E. coli K-12 clyA::luxAB operon
derivative JON33.
Transcription of clyA can be activated by the SfaX/PapX
transcriptional regulatory protein family encoded by
fimbrial gene clusters in UPEC strains
In E. coli K-12 the transcriptional regulator SlyA is known
to activate clyA+ transcription by counteracting the silen-
cing the H-NS nucleoid protein is causing [2,4,5,8]. How-
ever, the slyA gene seems to be present in most, if not all,
E. coli and the same is true for the hns gene, suggesting that
their role in clyA transcriptional regulation (anti-silencing
vs. silencing) would be conserved among different non-
pathogenic and pathogenic E. coli. Nevertheless, we per-
formed a multiple sequence alignment of the slyA promoter
region and coding sequences using a large set of publicly
available E. coli genome sequences (NCBI Reference
Sequence: NC_000913.3) to see if there would be any differ-
ences hinting to altered regulation of slyA expression
among different E. coli. It included sequences from different
E. coli pathotypes (ExPEC and non-ExPEC) and from
Figure 2 Introduction of a clyA+ locus in UPEC strains. (A) Schematic representation of the clyA loci in E. coli K-12 and in derivatives of
UPEC strain 536. In strain JON53 the clyA locus was restored in UPEC isolate 536 as described in Materials and Methods and a kanamycin
resistance gene was inserted downstream of clyA. The strain COE2 is a derivative of JON53 with a chimeric clyA::luxAB operon included adjacent to the
restored clyA+ locus. (B) Hemolysis activity tests with E. coli K-12 and UPEC derivatives on blood plates under Ca2+ depleted conditions due to addition of
Na-oxalate (final concentration 2 mM). Strains: 536 (UPEC, ΔclyA), JON53 (UPEC, clyA+), J96 (UPEC, ΔclyA), JON47 (UPEC, clyA+) MC1061 (K-12; clyA+), MG1655
( K-12; clyA+), MWK7 (K-12; ΔclyA). Tests were performed in absence (i) and in presence (ii) of Mitomycin C applied onto the center of horizontally streaked
rows of the E. coli strains. The images show the center part of the blood agar plates. (C) Detection of ClyA proteins by Western immunoblotting using a
polyclonal ClyA antiserum. The immunoreactive bands corresponding to ClyA are indicated with an arrow. Whole cell lysates (lanes 1–5) and periplasmic
fractions (lanes 6–10; prepared using osmolysis as described in Materials and Methods) were obtained from samples collected at OD600 = 2.0. Lanes 1 & 6:
UPEC strain 536. Lanes 2 & 7: strain JON53. Lanes 3 & 8: strain COE2. Lanes 4 & 9: strain MG1655. Lanes 5 & 10: strain MG1655 hns.
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region revealed that sequences corresponding to the
transcriptional and translational start sequences with the
regulatory sequence elements (−35, −10, and Shine-
Dalgarno sequences), as defined from studies of E. coli
K-12 derivatives, are completely conserved among the
many different E. coli isolates indicating that there would
be no obvious difference in slyA expression and regulation
(data not shown).Recent studies have shown that there are regulatory pro-
teins (the SfaX/PapX protein family) that show resemblance
to the SlyA protein and are encoded by genes in fimbrial
gene clusters typically occurring in UPEC isolates but
which are absent in E. coli K-12 [40-42]. We therefore
decided to investigate if the SlyA-like regulator SfaX might
influence the expression of the clyA locus. In UPEC strain
536 there are two fimbrial gene clusters, sfa and prs that
include genes for such regulatory proteins, SfaX and PrsX,
Figure 3 Immunofluorescence microscopy detection of ClyA on bacterial cells. Analyses were done with the E. coli K-12 strain MG1655
(A, B C), the clyA+ UPEC derivative JON53 (D, E, F) and the parental UPEC strain 536 (G, H, I). Panels A, D, G show images obtained by by phase
contrast microscopy. Panels B, E, H show images obtained from immunofluorescence analysis using polyclonal ClyA antiserum and AlexaFluor 555
–conjugated secondary antibody to enable visualization of ClyA as a red fluorescence signal. Panels C, F, I show the merged images.
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can influence expression of clyA we performed tests with
the sfaX+ wildtype and a mutant derivative of the ExPEC
strain IHE3034 which is known to have only one copy of
the sfaX gene family [41]. A plasmid construct with the
clyA+ gene under control of its natural promoter region
was introduced into strain IHE3034 and the sfaX::kan
derivative AES1. A mutant derivative (AES153) defective
in the sfaY gene located immediately upstream of sfaX in
the same operon was also included. The SfaY protein is
predicted to function as a c-di-GMP phosphodiesterase
and thereby indirectly involved also in the activity of the
transcriptional regulator SfaX [41]. It is also postulated
that the sfaY mutation is causing a polar effect that may
reduce sfaX expression. The phenotypic test of ClyA-
mediated hemolytic activity showed that colonies of the
wildtype strain IHE3034 caused stronger hemolysis than
the mutant derivatives indicating that its expression and/
or release of ClyA was higher than that of AES1 and
AES153 (Table 3). Western immunoblot analysis of ClyA
protein levels, using the plasmid encoded enzyme β-
lactamase as reference, indicated that the sfaX+ sfaY+ wild
type bacteria produced a somewhat higher level of ClyA
than the mutant derivatives (Figure 5).
As a more direct assessment of the potential influence of
the sfaX/papX regulatory gene products on clyA gene
transcription in a UPEC strain we tested what effectoverproduction of SfaX protein might have. A plasmid with
the cloned sfaX+ gene was introduced into the UPEC
derivative COE2 carrying the clyA::luxAB operons
construct in the chromosome. For comparison we included
a test with another regulator, the PapI protein known to be
part of a regulatory protein complex at the major promoter
region of the pap and sfa fimbrial gene clusters in UPEC
isolates [41]. The strain carrying the plasmid with the sfaX+
gene (pAES1) was named COE3, a vector plasmid control
strain was named COE4, and the strain carrying the
plasmid with the papI+ gene (pHMG95) was named COE6.
Samples for Luciferase activity measurements were taken
during the growth of these strains in LB medium
(Figure 6A). The results demonstrated that the UPEC strain
carrying the sfaX+ plasmid (strain COE3) had a greatly
enhanced level of clyA transcription. No such effect was
seen with the papI+ clone (strain COE6). These results
strongly support the suggestion that the presence of SfaX
protein in UPEC isolates can cause up-regulation of clyA
gene expression and that the effect could be stronger with
higher levels of SfaX/PapX proteins in such E. coli strains.
The clyA+ derivative of UPEC strain E. coli 536 has
increased susceptibility to the antimicrobial peptide
Polymyxin B
Considering the relatively high expression levels of the
pore-forming protein in the UPEC derivatives, we
Figure 4 Growth phase dependent clyA transcription. Bacteria
were grown in LB medium (A) at 37°C and samples were assayed
for luciferase activity as described in Materials and Methods. The strains
tested were: the UPEC derivative COE2 (clyA::luxAB), the E. coli K-12 strain
BSN26 (clyA::luxAB) and the UPEC strain 536 clyA+ (JON53) which was
serving as a luciferase negative control. The growth curves (upper panel)
are presented from a representative experiment. The data curves for
luciferase activity (lower panel) represent the average value of three
independent experiments and vertical bars indicate the standard
deviations. (B) Immunoblot detection of ClyA and CRP proteins. The
immunoreactive bands corresponding to ClyA and CRP are indicated with
arrows. Bacteria were grown in LB medium at 37°C. Whole cell lysates were
prepared from samples collected during different growth phases from the
logarithmic phase of growth until the stationary phase. Lane 1: UPEC strain
536. Lanes 2–5: strain JON53, OD600 = 1.6 (lane2), OD600 = 1.74 (lane 3),
OD600 = 2.24 (lane 4) and OD600 = 2.7 (lane 5). Lanes 6–9: COE2, OD600 = 1.5
(lane 6), OD600 = 1.8 (lane 7), OD600 = 2.04 (lane 8) and OD600 = 2.5 (lane 9).
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locus in strain 536 might influence its cell wall or mem-
brane properties and perhaps change its susceptibility to
antimicrobial compounds directed towards membranes.The strain JON53 was therefore cultured in medium
supplemented with serially diluted concentrations of dif-
ferent antimicrobial peptides (Polymyxin B, β-defensin
and LL-37), and with different concentrations of urea or
creatinine. We compared the MIC values for each anti-
microbial compound with the parental strain 536 and
the clyA+ derivative JON53. Our preliminary studies in-
dicated that there was no difference in MIC values be-
tween the two strains for either of the tested compounds
(Polymyxin B, β-defensin or LL-37; data not shown).
Likewise, there were no differences detected when differ-
ent concentrations of creatinine in the medium were
tested. However, when a sub-inhibitory concentration
(0,39 μg/ml, i.e. half the concentration of the observed
MIC value 0,78 μg/ml) was present in the medium the
clyA+ derivative JON53 displayed a somewhat slower growth
in presence of Polymyxin B, manifested as a more prolonged
lag, than the parental UPEC strain 536 (Figure 7A). The nor-
mal AUM medium contained 170 mM urea. At a two-fold
higher concentration (340 mM) of urea also the parental
UPEC strain 536 seemed more susceptible to the effect of
the sub-inhibitory concentration of Polymyxin B (Figure 7B).
At even higher concentrations of urea (510 mM or 680 mM)
the presence of Polymyxin B per se did not seem to alter the
growth much but both strains showed reduced growth. Not-
ably, it was evident that the higher concentrations of urea af-
fected growth of the clyA+ derivative JON53 more than that
of the parental ΔclyAUPEC isolate (Figure 7C & D).
The effect of Polymyxin B on growth was also moni-
tored with the E. coli K-12 strains MC4100 and
MWK11, the latter being a derivative of MC4100 with a
constitutive expression of ClyA protein due to an im-
proved binding site near the promoter for the cAMP-
CRP activating complex [8]. These strains showed a
similar MIC value (0,78 μg/ml) for Polymyxin B as the
UPEC strains. In the growth test with Polymyxin B at
half the MIC value (0,39 μg/ml) the higher ClyA expres-
sion did not cause any apparent disadvantage but when
Polymyxin B was added at a somewhat higher concentration
(0,48 μg/ml) the ClyA+ phenotype was correlated to reduced
growth also in the case of the E. coli K-12 derivatives (see
Additional file 2).
Discussion and conclusions
In Escherichia coli several different pore-forming cytoly-
sins have been identified. The one most extensively stud-
ied is α-hemolysin (HlyA), which is produced by many
uropathogenic E. coli (UPEC) strains and contributes to
virulence as shown in several animal models [43]. The
biological role of the ClyA protein, representing a novel
family of non-RTX toxins in Enterobacteriaceae, remains
to be discovered, although the distribution of the clyA
locus in a wide array of isolates would indicate that it
has an evolutionarily conserved function. The clyA gene
Table 3 Phenotypic test performed on blood agar plate1)
Bacterial strain Hemolytic phenotypes
IHE3034 (sfaX+) -
AES1 (sfaX::kan) -







1)The strains were grown on double blood agar plate and incubated overnight at
37°C prior to analysis of the phenotypes. (+++ = Strong hemolysis, ++ =Weak
hemolysis, + = very weak hemolysis and - = No hemolysis).
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coli isolates and in typhoid serovars of Salmonella enter-
ica [2,6,9,10].
A functional clyA gene was evidently lost through de-
letion(s) in several E. coli strains, e. g., in 19 of the 72
ECOR strains, and the ΔclyA alleles were present in a
number of different variants. Some strains carried
various deletions in the clyA coding sequence and in the
upstream region, resulting in truncated clyA loci. In the
majority of cases (ΔclyA versions I, II and III), the
function of the clyA locus may be effectively abolished
by two deletions, removing the promoter region and
portions of the N-terminal and central regions of the
coding sequence. In ECOR43 and ECOR44, a 12-bp
in-frame deletion (corresponding to amino acids 183–Figure 5 ClyA protein levels in derivatives of ExPEC strain IHE3034. (A
Samples were taken from cultures grown in LB medium at 37°C of the followin
(Δ sfaY); lane 4, IHE3034/pYMZ81; lane 5, AES1/pYMZ81; lane 6, AES153/pYMZ81
The immunoreactive bands corresponding to ClyA and the plasmid encoded β
arrowheads. (B) Quantification of relative ClyA levels in the strains IHE3034/pYM
levels as monitored in the image analyzer (see Methods). The data represent the
the standard deviations. An asterik indicates significance in difference according186 in ClyA) results in the expression, at a level similar
to that of the clyA+ derivative JON53, of a ClyA
polypeptide that was found to have no or very low
hemolytic activity (our unpublished data). The presence
of short repetitive DNA sequences at the junctions of
the major 493-bp deletion in ΔclyA variants I-III
(Figure 1A) and the 12-bp deletion of ΔclyA variant IV
(Figure 1B) suggests that these deletions may have been
formed as a result of slippage mispairing. The role of
direct repeats in deletion formation has been demon-
strated by sequence analysis of several deletion mutants
in E. coli [44-46]. Since no such repeats were identified
at the junctions of the other deletions, i. e. the 203- or
217-bp deletions in ΔclyA variants I-III (Figure 1B),
these deletions appear to have arisen by some other
mechanism(s). They could be the result of subunit ex-
change between DNA gyrase molecules, since this model
has been suggested for deletions terminating in sequences
that are neither directly nor inversely repeated [47,48]. It
also appears that after the functionality of a clyA locus
was lost, further alterations occurred, e.g., insertion of an
IS-2 element (strains ECOR61 and ECOR62), and non-
conservative point mutations in the clyA coding sequence.
Considering the possibility that there might be some
patho-adaptive selection for mutations in clyA of some
E. coli we restored, and studied the expression of, a func-
tional gene locus in the chromosome of the UPEC
isolate 536.
In order to determine if regulatory genes of fimbrial
gene clusters typically present in the chromosome of
UPEC can upregulate the expression of clyA, a plasmid) Effect of the sfaX-Y genes on the relative levels of ClyA protein.
g strains: lane 1, IHE3034 (sfaX+); lane 2, AES1 (sfaX::kan); lane 3, AES153
; lane 7, IHE3034/pUC18; lane 8, AES1/pUC18; lane 9, AES153/pUC18.
- Lactamase (used as the control in this experiment) are indicated with
Z81 and AES1/pYMZ81 calculated from the ratios of ClyA and β –Lactamase
average value of three independent experiments and vertical bars indicate
to Student’s t-test.
Figure 6 Effect of SfaX protein overproduction on expression of clyA. Transcription of clyA was monitored by luciferase measurements with
the clyA::luxAB UPEC restored construct COE2 carrying different plasmids as follows: COE2 carrying the sfaX+ plasmid clone pAES1 (COE3), COE2
carrying the vector pBR322 (COE4) and COE2 carrying the papI+ plasmid clone pHMG95 (COE6). The bacteria were grown in LB medium
(Figure 6) and the growth curve data are from representative experiments. The data showing relative Lux activities represent the average values
of three independent experiments and vertical bars indicate the standard deviations.
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UPEC derivative and we observed that the level of ClyA
was upregulated at the early stationary phase of growth.
Therefore, the sfaX gene does upregulate clyA expression.
Although the prevalence of E. coli strains with an
intact clyA gene in the ECOR A and B1 groups would
support the argument that ClyA has no direct role in
virulence, it cannot be ruled out that pathogenic rather
than non-pathogenic isolates under certain conditions
may express higher levels of ClyA and/or more effi-
ciently translocate the protein. In contrast to the com-
mensal strains, extraintestinal pathogenic E. coli are
mostly derived from group B2 and, to a lesser extent,
from group D [17-19]. There is a phylogeneticallyclustered distribution of the virulence-associated deter-
minants alpha-hemolysin (hly), type-II capsule (kps),
and P (pap) and S (sfa) fimbriae in the E. coli B2 and D
groups [18], and it has been suggested that the B2
strains should be considered highly virulent as evi-
denced by a mouse model of extra-intestinal virulence
[19]. Hence, the fact that every one of the 15 strains in
the B2 group of the ECOR collection contained a ΔclyA
allele [22] strongly suggests that E. coli strains adapted
for an extraintestinal lifestyle have the clyA gene de-
leted. On the other hand, it does not necessarily imply
that some selective condition(s) or mechanism(s) must
be found in the extraintestinal locations where E. coli
may reside.
Figure 7 (See legend on next page.)
Enow et al. BMC Microbiology 2014, 14:216 Page 11 of 16
http://www.biomedcentral.com/1471-2180/14/216
(See figure on previous page.)
Figure 7 Effect of Polymyxin B at a sub-inhibitory concentration on the growth of UPEC strain 536 and the clyA+ derivative JON53.
Note that the color codes for the strain JON53 and the blank are changed between panels A-B to C-D. The growth was monitored as optical
density at OD600nm and the plots show growth in presence of 0.39 μg/ml of Polymyxin B which is a concentration at half the observed MIC value
(0.78 μg/ml) in AUM medium with the following concentrations of urea: A) 170 mM; B) 340 mM; D) 510 mM; D) 680 mM.
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and sequencing of the mdh housekeeping gene, it was
concluded that pathogenic strains of E. coli do not have
a single evolutionary origin but have arisen on several
occasions [49]. Similarly, it appears unlikely that there is
a common ancestor for all ΔclyA strains, e. g. two ECOR
strains in the A group and one in the E group were
ΔclyA. The presence of different variants of the trun-
cated clyA locus suggests that clyA is a preferred target
for deletion mutations, and that such deletions have
arisen on several independent occasions. The adaptation
to a particular host may involve loss of virulence traits
that are important for infection of a wider spectrum of
animals [50]. Similarly, it is possible that the clyA locus
could be inactivated in the process of acquisition of new
genes (e. g., genes in PAIs) that would promote transi-
tion to an extra-intestinal lifestyle. One hypothesis con-
sistent with our present findings would be that the strict
regulation of clyA could be lost during this transition. In
E. coli K-12 the clyA locus is strictly regulated and its ex-
pression is silenced by the H-NS protein [39]. One
plausible explanation for the strict regulation in case of
such genes appearing as cryptic/silenced would be that
less strictly controlled alleles of such genes are disadvan-
tageous to the bacteria under certain environmental con-
ditions [51]. In this context it may be interesting to carry
out further studies with strains from ECOR group D that
seem to have an intact clyA+ locus whereas it remains to
be established if they produce ClyA protein and how ex-
pression is controlled.
In previous studies, it was demonstrated that epithelial
cells of the urinary tract in humans and mice secrete an
antimicrobial peptide, cathelicidin, upon contact with
UPEC and that the severity of the bacterial invasion is
linked to bacterial resistance to cathelicidin [52]. While
we did not detect any effect of the tested cathelicidin
(LL-37) on the growth of the bacteria, it remains to be
determined if the clyA+ UPEC derivative is more suscep-
tible to such peptides under in vivo conditions. We may
hypothesize that the mutations in the clyA gene were se-
lected for either under growth-limiting antimicrobial
peptide stress conditions in the urinary tract to which
bacterial cells are maladapted or under some other con-
dition of stress for example in the intestine where like-
wise the combination of a clyA+ allele and some other
trait(s) might be unfavourable. The mutations in the
clyA gene may adapt the bacteria to this stress condition
and thereby contribute to the bacterial survival aspathoadaptive events. The constructs described in this
work should allow us to test such hypotheses in suitable
model infection systems.
In order to test the potential impairment of membrane
integrity in the restored strain, the JON53 strain was
cultured in presence of the antimicrobial peptide Poly-
myxin B which can disrupt the integrity of the bacterial
cell membrane by interacting with its phospholipids.
The MIC value for Polymyxin B of JON53 was not al-
tered in comparison with the wild type UPEC strain 536
although there was a clearly detectable negative effect on
the growth of the clyA+ derivative JON53 when Polymyxin
B was added at a sub-inhibitory concentration. Also
higher concentrations of urea in the medium caused this
differential effect on the growth of the two strains.
Although a rather preliminary finding that will need to
be studied further, the observed higher susceptibility to
the antimicrobial peptide Polymyxin B that was seen in
the case of the UPEC with a restored clyA+ locus would
suggest that such a phenotype is more of a disadvantage
in the intestinal locations where other bacteria, e.g.
Bacillus, are producing antimicrobial peptides.
Methods
Bacterial strains and growth conditions
Sources and relevant characteristics of the bacterial
strains and plasmids used in this study are listed in
Table 1 and Table 4, respectively. Bacterial strains were
grown aerobically at 37°C on LB broth solidified with
1.5% (w/v) agar, or in Luria-Bertani (LB) broth, Poor
Broth (PB) [53], or artificial urine medium (AUM) [54].
Blood agar plates consisted of 5% horse erythrocytes so-
lidified with 1% (w/v) Columbia-Agar (base) (Merck),
which according to the manufacturer contains 2.3%
(w/v) special nutrient substrate. Ca2+ depleted condi-
tions were obtained by supplementing the blood agar
plates with Na-oxalate (final concentration 2 mM). Anti-
biotic selection was performed using 30 μg/ml kanamy-
cin, 12.5 μg/ml chloramphenicol, 50 μg/ml carbenicillin
or 15 μg/ml tetracycline.
Genetic techniques
Oligonucleotides were obtained from DNA Technology,
Aarhus, Denmark or from TAG Copenhagen, Copenhagen,
Denmark. DNA sequencing was performed using the ABI
PRISM™ Dye Terminator Cycle Sequencing Ready Reaction
Kit with AmpliTaq® DNA Polymerase, and an ABI PRISM™
377 DNA Sequencer. For PCR-screening, cloning and
Table 4 Plasmids used in this work
Plasmid Relevant characteristics Reference/source
pBR322 Cloning vector, Tcr [55]
pGEM®-T Easy T-vector for cloning of PCR-fragments, Cbr Promega
pJON77 3.1-kb subclone of clyA in pSL1180, Cbr This work
pJON78 3.1-kb subclone of clyA in pKO3, Cmr This work
pJON176 clyA+ kan in pJON78, Cmr Kmr This work
pKO3 Gene replacement vector, Cmr [56]
pMWK4 clyA::luxAB in pCH257, Cmr [8]
pAES1 pBR322, sfaXII gene from sfaII operon [41]
pHMG95 pBR322, lacP(UV5)papI+ clone [57]
pSL1180 Cloning vector, Cbr [58]
pUC4K Kanamycin resistance gene cartridge plasmid, Kanr [59]
pUC18 Cloning vector, Cbr [60]
pYMZ81 A 1.6-kb clyA locus in pUC18 [8]
pYMZ62 3.5-kb subclone of clyA in pUC18 [8]
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primers umu1 (5′-AATATTTGTCGCTGC-3′) and p79
(5′-TGTCAACAGGTAACTCTC-3′). The primers umu1
and p79 amplify a 1292-bp fragment starting 293 bp
upstream of the clyA start codon and ending 87 bp down-
stream of the stop codon, based on the sequence of the
E. coli K-12 clyA locus [2,61] and our data. Cloning of PCR-
amplified clyA-like sequences was performed using the
pGEM®-T Easy Vector System of Promega, as specified by
the manufacturer, and DH5α as a host strain.
Plasmid and strain construction
To construct clyA+ derivatives of E. coli 536 and J96, we
used the suicide plasmid pJON176 containing the clyA
wild type allele and a kanamycin resistance cassette lo-
cated 350 bp downstream of the clyA stop codon. The
construction of pJON176 was done as follows: A 3.5-kb
PvuII restriction fragment from plasmid pYMZ62
containing the clyA locus region (between nucleotide
positions 1,227,641 and 1,231,223 in the E. coli K-12
genome) was inserted into EcoRV-digested pSL1180
which resulted in the construction of pJON77. The
plasmid pJON77 was digested to yield a 3.2-kb PvuII-
BamHI fragment that was subsequently ligated into the
BamHI-SmaI-digested pKO3 suicide donor plasmid thus
resulting to the construct pJON78. A 1.3-kb PstI restric-
tion fragment which contains the kanamycin resistance
gene from the plasmid pUC4K was then ligated into the
NsiI restriction site of pJON78, i. e. 350 bp downstream
of the clyA stop codon, to generate the construct
pJON176. The clone included the entire 0,4 kb intercis-
tronic region and sequences into the umuD gene
upstream of clyA such that the otherwise deleted pro-
moter region in the UPEC strains could be restored.Using pJON176 the clyA locus and kanamycin resistance
gene was introduced into the chromosome of the E. coli
strains 536 and J96, as previously described [54], to
generate the strains JON53 and JON47, respectively.
For the purpose of quantitatively determining the level
of clyA gene transcription, we introduced a clyA-luxAB
operon construct using the suicide plasmid pMWK4 [8].
The pMWK4 plasmid contains DNA corresponding to
the sequence 290 bp upstream of clyA and 76 bp into
the clyA coding sequence. The pMWK4 plasmid was
integrated in tandem to clyA in the chromosome of
JON53 by a single recombination event. The resulting
strain was designated COE2 (JON53 - clyA::luxAB).
The plasmids pAES1 and pHMG95 were introduced
into the strain COE2 by electroporation and the trans-
formants were selected on LB agar plates containing
12.5 μg/ml chloramphenicol, 30 μg/ml kanamycin and
50 μg/ml carbenicillin as appropriate. The resulting
strains were designated COE3 (COE2/pAES1), COE4
(COE2/pBR322) and COE6 (COE2/pHMG95).ClyA expression assays
Lytic activity of the UPEC and K-12 strains were ana-
lysed using a double horse blood agar plate. The blood
agar plate was supplemented with 2 mM of Sodium–ox-
alate ( Ca2+ chelator ). Bacteria were streaked into verti-
cal lines across the plate and 1.5 μl of 0.5 mg/ml of
Mitomycin C was dripped onto the horizontally streaked
rows of strains prior to incubation at 37°C for maximum
16 hours. Mitomycin C triggers the bacterial SOS re-
sponse and hence induces the proliferation of lysogenic
phages (Walker, 1996) and thus may cause release of cy-
tolysin A that lyses the blood [9].
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Approximately five bacterial colonies grown on an LB plate
overnight were suspended in 100 μl water or PBS, and 10
to 20 μl of the suspension was placed on a glass slide and
air-dried. The cells were fixed with 4% paraformaldehyde
(PFA) in PBS for 10 minutes and wash with PBS. The slides
were covered for 20 min with 0.1 M glycine diluted in PBS,
followed by washes in PBS then blocked with 1% BSA in
PBS for 30 min. Polyclonal ClyA antiserum was diluted in
a blocking solution and then added to the bacteria on the
slide at a final dilution of 1:3,000 and incubated for 2 hours
at room temperature or overnight in 4°C. Alexa Fluor 555
anti-rabbit IgG (Invitrogen) diluted 1:500 in blocking solu-
tion was applied to the bacterial cells for 1 hour at room
temperature. Washes in 1 × PBS for 15 min were repeated
five times and the bacteria were then mounted in a fluores-
cence mounting medium (Dako). The slides were examined
at 1000× magnification with a Nikon Intensilight C-HGFI
system microscope equipped for fluorescence; the images
were obtained with a Hamamatsu DRCA-ER camera.
Measurement of luciferase (lux) activity
Colonies of the bacterial strains MG1655 (K-12), JON53-
clyA+::luxAB (COE2), COE3, COE4 and COE6, from
plates incubated overnight were inoculated into LB broth
medium. The bacteria were cultured aerobically at 37°C.
The optical density (OD600nm) was measured during
growth at different time points. In parallel, the transcrip-
tional activity was measured in a Sirius luminometer using
decanal as a substrate. One hundred μl of a 0.1% v/v sus-
pension of decanal (Sigma) in water was added to 100 μl
of bacterial culture as programmed by the Sirius instru-
ment and light emission was measured. Triplicates were
measured for each sample and specific activity (lux activity
units/OD600nm) was calculated and plotted.
Sub-cellular localization of ClyA in K-12 and UPEC
derivatives
Sub-cellular fractionation was performed essentially as
explained before [62]. For sub-cellular localization of
ClyA, E. coli cells were grown in LB medium at 37°C
until late logarithmic phase (OD600nm ≈ 2). To prepare
whole cell lysate fractions, the bacteria (1 ml) were cen-
trifuged at 12,000 × g for 5 min and the bacterial pellet
was resuspended in (80 ul) 20 mM Tris–HCl pH 8.0 buf-
fer. SDS-polyacrylamide gel electrophoresis (SDS-PAGE)
analyses of proteins were performed as described previ-
ously [63]. Five μl (from 80 μl) of the bacterial suspensions
were loaded in the well. To prepare periplasmic fractions,
bacterial suspensions (1.5 ml) with a cell density of
approximately 5 × 109/ml were harvested by centrifugation.
The pellet was washed twice with 10 mM Tris–HCl
(pH 8.0) three times and resuspended in 20 mM Tris–HCl
(pH 8.0), 20% (wt/vol) sucrose, and 0.1 mM EDTA at 25°C.After 10 min the cells were pelleted and resuspended in
sterile distilled water. After incubation on ice for 10 min,
the cells were removed by centrifugation at 12,000 × g.
The supernatant was used as the periplasmic fraction. Peri-
plasmic proteins were concentrated by precipitation with
ice-cold 10% trichloroacetic acid containing 1 mg/ml deox-
ycholate. The precipitated proteins were collected by cen-
trifugation at 12,000 × g, washed with acetone, dried under
vacuum, and dissolved in sample buffer (50 mM Tris–HCl
(pH 6.8), 10% glycerol, 5% β-mercaptoethanol, 2% sodium
dodecyl sulfate (SDS), 0.05% bromophenol blue). Samples
were neutralized by addition of saturated Tris solution and
boiled for 5 min at 100°C.
Western blot analysis
Western immunoblotting was performed as previously
described [64]. The proteins were detected using differ-
ent primary polyclonal antisera: polyclonal anti-ClyA
antiserum [6], and the anti-CRP polyclonal antiserum
[62] recognizing E. coli cyclic AMP receptor protein
(CRP), which was used as an internal control for cyto-
plasmic protein and antiserum recognizing TEM-β lacta-
mase [62] which was used as the periplasmic protein
loading control for strains carrying carbenicillin resist-
ance plasmids. The immunoreactive bands were visual-
ized by scanning using a luminescent image analyzer
LAS 4000 IR multi-color (Fujifilm) and/or by exposure
on the Hyper film (Amersham Biosciences).
Antimicrobial assays
MIC determination: Liquid growth inhibition assays were
performed essentially as described earlier [53]. Briefly, ~5
bacterial colonies from an overnight culture plate were
suspended in Poor Broth (PB) medium (1% Bactotryptone,
pH 7.5) or artificial urine media (AUM) and grown aerob-
ically at 37°C overnight. Bacterial suspensions were diluted
to an OD600nm = 0.01 and grown to approximately
OD600nm 0.2 - 0.4 to obtain an exponential phase culture.
In a flat-bottom 96-well plate (Falcon), 95 μl of the
medium was added to all wells, 5 μl of the bacterial cul-
ture (OD600nm = 0.2) was added to each well at a final
OD600nm of 0.001 (1 × 10
5 cells/110 μl) and a 10 μl sample
of two-fold serially diluted solutions of the peptide (poly-
myxin B, β-defensin or LL-37) was added to obtain a
range from highest (50 μg/ml) to lowest (0.097 μg/ml)
concentrations in the series of wells containing bacteria
and medium. To determine the effects of some of the
components in AUM, media containing higher concentra-
tions of urea (i.e. 340 mM – 680 mM) and twice the con-
centration of creatinine (i.e. 14 mM) were used.
The positive control wells contained only bacteria and
medium while the negative control well contained medium
and water. The plate was incubated for 16 hours aerobically
at 37°C in a TECAN Infinite M200 fluorescence multiplate
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absorbance at OD600nm at 5 minute intervals. MIC values
are defined as the lowest concentration that causes 100%
growth inhibition. The following Polymyxin B susceptible
and resistant organisms were used as controls: V. cholerae
strain 569B (MIC = 1.5 μg/ml), V. cholerae strain A1552
(MIC = 50 μg/ml), E. coli strain MC4100 (MIC = 7.8
μg/ml), E. coli strain MWK11 (MIC = 7.8 μg/ml).
Additional files
Additional file 1: The open access software programs BLAST
(http://blast.ncbi.nlm.nih.gov/Blast.cgi) to search for sequences and
strains with similarities to the clyA/hlyE gene, and ClustalW
(http://pbil.ibcp.fr/htm/index.php) were used for alignment of the
sequences with the clyA gene sequences of E. coli strain MG1655
(accession number of NC_000913.3) as the reference sequence. It
includes the 1.2 kb region between nucleotide coordinates 1229483 and
1230694 and represents the entire clyA coding sequence and 300 base
pairs upstream of the ATG start codon. The sequence of clyA was
compared with the corresponding sequences of clyA in other E. coli
strains (both IPEC and ExPEC). Black nucleotide lettering and dashes
indicates position where there are differences in the otherwise red letter
compilation. The translational start sequences (ATG and ribosome binding
motif) are marked in green. The transcriptional start sequences −35 and −10
motifs and the initiating nucleotide are marked in blue. The binding site for
the CRP/FNR regulators is marked in grey. The binding sequences for SlyA
are underlined.
Additional file 2: Effect of Polymyxin B on the growth of E. coli
K-12 derivatives MC4100 and MWK11 in batch cultures of medium
AUM at 37°C.
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